We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTRTW
3476
CALL
DELISTED
DTRT Health Acquisition Corp. Warrant
DTRTW
-77,090
Closed -$799K
KNBE
3477
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
-182,500
Closed -$4.52M
SJI
3478
DELISTED
South Jersey Industries, Inc.
SJI
-446,324
Closed -$15.9M
CPARW
3479
CALL
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
-119,995
Closed -$1.21M
CPAR
3480
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
-1,391,488
Closed -$14M
VIVO
3481
DELISTED
Meridian Bioscience Inc
VIVO
-153,227
Closed -$5.09M
DNZ.WS
3482
CALL
DELISTED
D and Z Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
DNZ.WS
-404,237
Closed -$4.04M
GIAC
3483
DELISTED
Gesher I Acquisition Corp. Class A Ordinary Shares
GIAC
-495,340
Closed -$5.03M
NAACW
3484
CALL
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
-354,441
Closed -$3.58M
SVFA
3485
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
-1,008,115
Closed -$10.2M
NAAC
3486
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
-2,106,129
Closed -$21.3M
THAC
3487
DELISTED
Thrive Acquisition Corporation Class A ordinary shares
THAC
-770,948
Closed -$7.97M
THACW
3488
CALL
DELISTED
Thrive Acquisition Corporation Warrant
THACW
-385,474
Closed -$3.99M
JCIC
3489
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
-1,186,829
Closed -$12M
JCICW
3490
CALL
DELISTED
Jack Creek Investment Corp. Warrants
JCICW
-409,376
Closed -$4.15M
BNFT
3491
DELISTED
Benefitfocus, Inc.
BNFT
-87,927
Closed -$920K
ARCKW
3492
CALL
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Warrants
ARCKW
-150,519
Closed -$1.7M
TZPS
3493
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
-1,268,407
Closed -$12.8M
AEACW
3494
CALL
DELISTED
Authentic Equity Acquisition Corp. Warrant
AEACW
-444,211
Closed -$4.49M
AEAC
3495
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
-752,793
Closed -$7.61M
TZPSW
3496
CALL
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
-366,658
Closed -$3.7M
DLCA
3497
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
-307,078
Closed -$3.1M
DLCAW
3498
CALL
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
-445,024
Closed -$4.49M
FCAX
3499
DELISTED
Fortress Capital Acquisition Corp.
FCAX
-1,050,223
Closed -$10.6M
FINM
3500
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
-722,864
Closed -$7.32M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.